Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4713 results found.

Example of search result explained

Simlandi (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114144
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114146

Simlandi (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114151

Yuflyma (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114225
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114227

Yuflyma (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 100 mg/mL (0,4 mL) DIN : 99114233
    • Subcutaneous Injectable Solution 100 mg/mL (0,8 mL) DIN : 99114228

Amgevita (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114035
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114046

Hulio (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 50 mg/mL (0,4 mL) DIN : 99114041
    • Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114042

Abrilada (syringe)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114033

Abrilada (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114034

Amgevita (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    Amgen Canada Inc. (Amgen)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114047

Hulio (pen)

Exceptional medication
  • Active ingredient(s):
    adalimumab (hidradenitis suppurativa)
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    Subcutaneous Injectable Solution 50 mg/mL (0.8 mL) DIN : 99114043
Page 13 of 472

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.